That version of the medication is called Zepbound
Data Sheet Application: Research on metabolism, obesity, fatty liver disease, exercise performance, inflammation, neuroprotection, and cardiovascular disease
It's important to note that when used as monotherapy, GLP-1 receptor agonists like semaglutide have a low risk of causing hypoglycemia
Poorly controlled diabetes can lead to heart disease, kidney damage, nerve problems, and vision issues
Borzoei A, Rafraf M, Niromanesh S, Farzadi L, Narimani F, Doostan F
Total GLP-1 was analyzed by a chemiluminescent enzyme-linked assay (Mercodia, Uppsala, Sweden, Catalog # 10-1278-01, RRID: AB_2892202) with, according to the manufacturer, a 100% specificity to the GLP-1 (936) amide